Rodolfo Alejandro
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rodolfo Alejandro sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Rodolfo Alejandro: 10 sponsored US clinical trials, 3 recruiting.
Rodolfo Alejandro sponsors 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 1 Diabetes Mellitus, with 3 trials.
Top-decile sponsor footprint
Rodolfo Alejandro ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
Long Term Follow up of Recipients of Functional Islet Allografts
NCT01999374
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
NCT01999361
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
NCT02000687
Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
NCT03406897
Allogeneic Islet Cells Transplanted Onto the Omentum
NCT02213003
Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
NCT01786707
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
NCT02004964
Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation
NCT00315627
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
NCT00315588
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
NCT00306098
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Rodolfo Alejandro pipeline
3 recruiting of 10 indexed (30% open); 7 completed (70%).
Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Type 1 Diabetes Mellitus (3 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rodolfo Alejandro: open-pipeline peers nationwide
Peers matched on 10 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
Rodolfo Alejandro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 30% open enrollment (± trial volume)
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
- Child Trends · 30% recruiting · 10 trials
- Jacques E. Chelly · 30% recruiting · 10 trials
- Jason Sperry · 30% recruiting · 10 trials
Related
What to do with this Rodolfo Alejandro page
10 registered trials is a research-attention snapshot, not an endorsement of Rodolfo Alejandro or any single study.
- 3 of Rodolfo Alejandro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes Mellitus is the condition Rodolfo Alejandro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes Mellitus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rodolfo Alejandro pipeline card: 10 registered trials from official public datasets.Report a data error.